<qa>  What is the clinical activity of ASLAN001 in combination with capecitabine?This is an open-label, randomized, parallel group Phase 2A2B study to evaluate the clinical activity of ASLAN001 in combination with capecitabine compared with lapatinib in combination with capecitabine in patients with HER2 positive metastatic breast cancer that has failed on prior trastuzumab therapy. 